Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

被引:146
作者
Greenfield, JR
Samaras, K
Jenkins, AB
Kelly, PJ
Spector, TD
Gallimore, JR
Pepys, MB
Campbell, LV
机构
[1] St Vincents Hosp, Ctr Diabet, Darlinghurst, NSW 2010, Australia
[2] St Vincents Hosp, Dept Endocrinol, Darlinghurst, NSW 2010, Australia
[3] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia
[4] Univ Wollongong, Dept Biomed Sci, Wollongong, NSW 2500, Australia
[5] Orchid Biosci Inc, Princeton, NJ USA
[6] St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London, England
[7] UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, Dept Med, London, England
关键词
obesity; inflammation; syndrome X; lipids;
D O I
10.1161/01.CIR.0000130640.77501.79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - C-reactive protein (CRP) values predict atherothrombotic cardiovascular disease and type 2 diabetes mellitus. Associations between CRP and obesity, predominantly assessed anthropometrically, may partly explain these observations. Previous studies have been unable to control for genetic influences on CRP and obesity. The aim of this study was to examine the relationship between CRP and accurately measured body fat, lipids, apolipoproteins, blood pressure, and environmental and behavioral factors, independent of genetic influences. Methods and Results - One hundred ninety-four healthy female twins ( age 57.2 +/- 7 years) were studied after excluding pairs with CRP values > 10 mg/L. Total body fat and central abdominal fat (CAF) were measured by dual-energy x-ray absorptiometry. CRP concentration was strongly related to surrogate and direct measures of body fat ( r = 0.31 to 0.54, P < 0.001), diastolic blood pressure ( r = 0.20, P = 0.003), and lipid and apolipoprotein levels ( r = 0.21 to 0.51, P < 0.008). Light-to-moderate alcohol consumers and nonusers of hormone replacement therapy (HRT) had lower CRP levels than abstainers and HRT users, respectively. In stepwise multiple regression analysis, CAF, triglycerides, apolipoprotein B, and HRT use explained 46% of the variance in circulating CRP. In analyses controlling for genetic influences in monozygotic twins, within-pair differences in CRP were associated with within-pair differences in total body fat ( r = 0.39, P < 0.001), CAF ( r = 0.34, P = 0.002), diastolic blood pressure ( r = 0.24, P = 0.03), apolipoprotein AI ( r = -0.33, P = 0.01), HDL cholesterol ( r = - 0.42, P = 0.001), and triglycerides ( r = 0.35, P = 0.007). Conclusions - CRP was strongly related to total and central abdominal obesity, blood pressure, and lipid levels, independent of genetic influences. These relationships are likely to contribute significantly to prospective associations between CRP and type 2 diabetes and coronary events.
引用
收藏
页码:3022 / 3028
页数:7
相关论文
共 62 条
  • [51] Stewart Scott H, 2002, J Am Board Fam Pract, V15, P437
  • [52] Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene
    Szalai, AJ
    McCrory, MA
    Cooper, GS
    Wu, J
    Kimberly, RP
    [J]. GENES AND IMMUNITY, 2002, 3 (01) : 14 - 19
  • [53] Weight loss reduces C-reactive protein levels in obese postmenopausal women
    Tchernof, A
    Nolan, A
    Sites, CK
    Ades, PA
    Poehlman, ET
    [J]. CIRCULATION, 2002, 105 (05) : 564 - 569
  • [54] C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men -: Results from the MONICA Augsburg Cohort Study, 1984-1998
    Thorand, B
    Löwel, H
    Schneider, A
    Kolb, H
    Meisinger, C
    Fröhlich, M
    Koenig, W
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (01) : 93 - 99
  • [55] Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein
    Vickers, MA
    Green, FR
    Terry, C
    Mayosi, BM
    Julier, C
    Lathrop, M
    Ratcliffe, PJ
    Watkins, HC
    Keavney, B
    [J]. CARDIOVASCULAR RESEARCH, 2002, 53 (04) : 1029 - 1034
  • [56] Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians
    Weyer, C
    Yudkin, JS
    Stehouwer, CDA
    Schalkwijk, CG
    Pratley, RE
    Tataranni, PA
    [J]. ATHEROSCLEROSIS, 2002, 161 (01) : 233 - 242
  • [57] WHO Expert Committee on Biological Standardization, 1987, WHO TECHN REP SER, V760, P21
  • [58] Wilkins J, 1998, CLIN CHEM, V44, P1358
  • [59] Coming of age of C-reactive protein - Using inflammation markers in cardiology
    Yeh, ETH
    Willerson, JT
    [J]. CIRCULATION, 2003, 107 (03) : 370 - 372
  • [60] Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
    Yudkin, JS
    Kumari, M
    Humphries, SE
    Mohamed-Ali, V
    [J]. ATHEROSCLEROSIS, 2000, 148 (02) : 209 - 214